Outcomes of refractory and early-relapsed large B-cell lymphoma patients after first-line treatment in the prospective Real-world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre-CAR T era.

Guidez S, Belot A, Cherblanc F, Lesné B, Carras S, Thieblemont C, Bijou F, Rossi C, Fornecker LM, Dupuis J, Bouabdallah K, Fouillet L, Chauchet A, Tessoulin B, Ysebaert L, Pauc A, Cony-Makhoul P, Gressin R, Laboure G, Bonnet A, Amorim S, Fruchart C, Houot R, Pica GM, Soussain C, Dennetiere S, Leyronnas C, Lionne-Huyghe P, Ghesquières H, Sesques P

Open source

DOI
10.1111/bjh.70812
Published
2026 Aug 30
Container
British journal of haematology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70812,
  title = {Outcomes of refractory and early-relapsed large B-cell lymphoma patients after first-line treatment in the prospective Real-world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre-CAR T era.},
  author = {Guidez S and Belot A and Cherblanc F and Lesné B and Carras S and Thieblemont C and Bijou F and Rossi C and Fornecker LM and Dupuis J and Bouabdallah K and Fouillet L and Chauchet A and Tessoulin B and Ysebaert L and Pauc A and Cony-Makhoul P and Gressin R and Laboure G and Bonnet A and Amorim S and Fruchart C and Houot R and Pica GM and Soussain C and Dennetiere S and Leyronnas C and Lionne-Huyghe P and Ghesquières H and Sesques P},
  year = {2026},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.70812},
  url = {https://doi.org/10.1111/bjh.70812}
}

RIS

TY  - JOUR
TI  - Outcomes of refractory and early-relapsed large B-cell lymphoma patients after first-line treatment in the prospective Real-world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre-CAR T era.
AU  - Guidez S
AU  - Belot A
AU  - Cherblanc F
AU  - Lesné B
AU  - Carras S
AU  - Thieblemont C
AU  - Bijou F
AU  - Rossi C
AU  - Fornecker LM
AU  - Dupuis J
AU  - Bouabdallah K
AU  - Fouillet L
AU  - Chauchet A
AU  - Tessoulin B
AU  - Ysebaert L
AU  - Pauc A
AU  - Cony-Makhoul P
AU  - Gressin R
AU  - Laboure G
AU  - Bonnet A
AU  - Amorim S
AU  - Fruchart C
AU  - Houot R
AU  - Pica GM
AU  - Soussain C
AU  - Dennetiere S
AU  - Leyronnas C
AU  - Lionne-Huyghe P
AU  - Ghesquières H
AU  - Sesques P
PY  - 2026
JO  - British journal of haematology
DO  - 10.1111/bjh.70812
UR  - https://doi.org/10.1111/bjh.70812
ER  - 

APA

S, G., A, B., F, C., B, L., S, C., C, T., F, B., C, R., LM, F., J, D., K, B., L, F., A, C., B, T., L, Y., A, P., P, C., R, G., G, L., A, B., S, A., C, F., R, H., GM, P., C, S., S, D., C, L., P, L., H, G., & P, S. (2026). Outcomes of refractory and early-relapsed large B-cell lymphoma patients after first-line treatment in the prospective Real-world dAta in LYmphoma patients and Survival in Adults (REALYSA) cohort in the pre-CAR T era.. British journal of haematology. https://doi.org/10.1111/bjh.70812

Source records